共 50 条
Immunotherapy for pediatric brain tumors: past and present
被引:31
|作者:
Foster, Jessica B.
[1
,2
]
Madsen, Peter J.
[3
]
Hegde, Meenakshi
[4
,5
]
Ahmed, Nabil
[4
,5
]
Cole, Kristina A.
[1
,2
]
Maris, John M.
[1
,6
]
Resnick, Adam C.
[3
,7
]
Storm, Phillip B.
[3
,7
]
Waanders, Angela J.
[8
]
机构:
[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA
[4] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[6] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA
[8] Ann & Robert H Lurie Childrens Hosp Chicago, Div Oncol, Chicago, IL 60611 USA
关键词:
brain tumor;
immunotherapy;
pediatric;
ACTIVATED KILLER-CELLS;
WT1 PEPTIDE VACCINATION;
MALIGNANT PRIMARY BRAIN;
T-CELLS;
ADOPTIVE IMMUNOTHERAPY;
ANTIGEN PEPTIDES;
HEMATOLOGICAL MALIGNANCIES;
IMMUNE-RESPONSES;
YOUNG-ADULTS;
GLIOBLASTOMA;
D O I:
10.1093/neuonc/noz077
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
The field of cancer immunotherapy has progressed at an accelerated rate over the past decade. Pediatric brain tumors thus far have presented a formidable challenge for immunotherapy development, given their typically low mutational burden, location behind the blood-brain barrier in a unique tumor microenvironment, and intratumoral heterogeneity. Despite these challenges, recent developments in the field have resulted in exciting preclinical evidence for various immunotherapies and multiple clinical trials. This work reviews the history and advances in active immunotherapy, checkpoint blockade, and adoptive T-cell therapy for pediatric brain tumors, including ongoing clinical trials.
引用
收藏
页码:1226 / 1238
页数:13
相关论文